Table 6_High-dose accelerated intermittent theta burst stimulation targeting the primary m

36 patients with cerebral small vessel disease participated in a randomized, single-blind, sham-controlled trial of high-dose accelerated intermittent theta burst stimulation. The dataset includes primary and secondary outcome measures for gait and cognitive function, collected at baseline, post-intervention, and a 4-week follow-up. The data was authored by Xiao-Ying Zhao and shared under a CC-BY-4.0 license.

Use Cases

• Analyze treatment efficacy based on the 3-meter Timed Up and Go (3mTUG) duration primary outcome
• Investigate correlations between neuroimaging phenotypes and clinical response based on CSVD burden scores mentioned
• Compare multidimensional functional scale scores between real and sham stimulation groups
• Model longitudinal changes in gait and cognitive metrics from baseline through follow-up assessments

Strengths

• Data originates from a randomized controlled trial with 36 patients (19 real, 17 sham), a standard study design.
• Includes longitudinal measurements from three time points: baseline, post-intervention, and a 4-week follow-up.
• License is CC-BY-4.0, permitting broad reuse and modification.

Limitations

• Dataset is very small at 10.2 KB, indicating limited scope and sample size.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment for some analyses.

Provenance

Source

figshare

Collection Method

Collected as part of a randomized, single-blind, sham-controlled clinical trial.

Freshness

Last updated 2026-06-01 05:24:50; freshness should be verified.